RIVM is actively participating in national and international projects on alternatives to animal testing. On this page, we present an overview of all our (inter)national projects on this topic.
| Project | Programme | Fields of expertise | Keywords | Duration |
|---|---|---|---|---|
| CHIASMA | Horizon Europe | SSbD | enivronmental risk assessment | chemicals3Rs | alternatives animal testing | 2024-2027 | |
| Better In-vitro Dosing | Create2Solve | In vitro testing of inhaled substances | difficult-to-test substances | in vitro assays | 3Rs | 2023-2028 |
| MERLON | Horizon Europe | Stem cell, zebrafish | 3Rs | endocrine disruption | chemicals | youth | 2023-2028 |
| INTACT | Strategic Programme RIVM | Non-animal methods | risk assessment | computational toxicology | in vitro assays | chemicals | 2023-2027 | |
| Cells4Thought | Strategic Programme RIVM | Stem cells | Non-animal methods | in vitro assays |chemicals | youth | 2023-2027 |
| NAMs4Nano | EFSA | Zebrafish | nanomaterials | 3Rs | risk assessment | 2023-2027 |
| AFARA | Nationale Wetenschapsagenda | In vitro testing of inhaled substances | Endocrine disruption | non-animal methods | in vitro assays | testing strategy | transition science | 2023-2028 |
| MACRAME | Horizon Europe | In vitro testing of inhaled substances | advanced materials | life-cycle | hazard | 2022-2025 |
| SURPASS | Horizon 2021 | plastics | polymers| safe-and-sustainable-by-design (SSbD) | endocrine disruption | testing strategy | 2022-2025 | |
| Inno4Vac | Horizon 2020 | vaccines | vaccine development | vaccine efficacy | 2021-2027 | |
| PARC | Horizon Europe | In vitro testing of inhaled substances; zebrafish | risk assessment | chemicals | mixtures of chemicals | 2021-2026 |
| RISKHUNT3R | Horizon 2020 | Non-genotoxic carcinogens; stem cells | 3Rs | non-animal methods | 2021-2026 |
| VHP4Safety | Nationale Wetenschapsagenda-Onderzoek op Routes door Consortia | Stem cells; zebrafish; Computational modelling of neural tube defects | Non-animal methods | risk assessment | computational toxicology | in vitro assays | FAIR principles | transition science | 2021-2026 |
| ONTOX | Horizon 2020 | Computational modelling of neural tube defects |
computational toxicology | probabilistic risk assessment | 3Rs | 2021-2026 |
| REAL | Strategic Programme RIVM | In vitro testing of inhaled substances | environmental risk factors | In vitro assays | infectious diseases | 2021-2025 |
| MOMENTUM | ZonMw, Health~Holland | In vitro testing of inhaled substances | microplastics | in vitro assays | hazard | risk assessment | 2021-2024 |
| DARTBAC | Nationale Wetenschapsagenda | Medical implant safety | safe-by-design | anti-microbial technologies | in vitro assays | 2020-2026 |
| Mechanotox | Strategic Programme RIVM | Medical implant safety | mechanotox | biomaterials | in vitro assays | 2020-2024 |
| SAbyNA | Horizon 2020 | SSbD, in vitro testing of inhaled substances | nanomaterials | nano-enabled products | safe-and-sustainable-by-design (SSbD) | hazard testing strategy | inhalation | 2020-2024 |
| ATHLETE | Horizon 2020 | Stem cells | exposome | environmental risk factors | youth | 2019-2025 |
| COMPAIR | Strategic Programme RIVM | In vitro testing of inhaled substances | environmental risk factors | In vitro assays | infectious diseases | intensive livestock farming | 2019-2022 |
| OrganoVIR | Horizon 2020 | virology | organoids | replacement animal testing | 2019-2022 | |
| PATROLS | Horizon 2020 | In vitro testing of inhaled substances | safe and sustainable use of new technologies and products | nanotechnology | risk assessment | in vitro | 2018-2022 |
| VAC2VAC | IMI | vaccine provision | alternatives animal testing |replacement reduction refinement of animal use | 2016-2022 | |
| EUROMIX | Horizon 2020 | Zebrafish | food safety | safe and sustainable use of chemicals | 2015-2019 |